As you comb through the web pages, it’s clear the product is meant for a multi-level marketing scheme.  Many of these companies do not expect anyone to actually use the product.  They just  want people who will buy it in hopes of selling it to someone else.  One previous potential customer has said he could not buy the product, as the company demanded a referral.  This means multi-level marketing might be their main business.  This can lead to problems getting the product for regular consumers, though they do have an option to sell directly to the consumer as well on the website.
During this time, both the FDA announced that it had approved the “first drug containing cannabidiol” for epilepsy and a spokeswoman for the DEA, commenting generally on the agency’s reported seizure of hemp destined for a CBD oil manufacturer in North Carolina, said that “as far as the federal government is concerned, CBD oil is illegal.” That’s two federal agencies that both have the word “drug” in their names appearing to contradict each other, mere weeks apart. So suffice to say, it’s cloudier than a Cheech and Chong cast party right now.
The human body has an endocannabinoid system — a natural system that maintains homeostasis or balance, in the body. The endocannabinoid system has CB1 and CB2 receptors. These are found throughout the body. CB1 receptors are generally located in the central and peripheral nervous system and CB2 receptors are generally found in the brain, immune system, and gastrointestinal system. CBD binds to these receptors creating changes and effects in the body
The heat is very much on CBD oil sellers these days as the FDA continues to crack down on companies selling “questionable” (to put it nicely) hemp-based products. In fact, since 2015 – when the FDA first issued warning letters to multiple CBD sellers – the industry has been forced to clean up its act, at least in terms of manufacturing operations and brand transparency.
×